Across TCGA pan-cancer cohorts, RPS15AP7 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RPS15AP7’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RPS15AP7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS15AP7 is over-expressed in tumor.
LUSC are the cancer types where RPS15AP7 tumor–normal differential expression is most reproducible.